prostate cancer
Conditions
Interventions
Full Pain Management Group (intervention group):Compound lidocaine cream was applied to the perineal skin, mucosa of the anterior rectal wall and perianal area before biopsy
Routine Pain Management Group (control group):Placebo was applied to the perineal skin, mucosa of the anterior rectal wall and perianal area before biopsy
Sponsors
Lishui Central Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: ? Aged >=18 years; ? Suspicious nodules of the prostate found by digital rectal examination; ? Suspicious lesions found by transrectal ultrasound or magnetic resonance imaging; ? PSA > 10ng/ml; ? PSA 4~10ng/ml, f/t PSA0.15ng/ml.
Exclusion criteria
Exclusion criteria: ? Chronic pelvic pain syndrome; ? Chronic prostatitis; ? Previous prostate biopsy; ?Allergy to proparacaine or lidocaine; ? Coagulation disorders, should not perform prostate biopsy; ? Acute urinary tract infection or fever; ? Internal hemorrhoids, external hemorrhoids, perianal or rectal lesions; ? Withdrawal from the study; ? circumstances that require withdrawal as assessed by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain visual analog scale score; | — |
Secondary
| Measure | Time frame |
|---|---|
| detection of prostate cancer;Willingness to repeat biopsy;Post-operative complications; | — |
Countries
China
Contacts
Public ContactLi Jie
Lishui Central Hospital
Outcome results
None listed